SCHEMBL9944799

SCHEMBL9944799

CNc1cc(N2CCC(C)CC2)c(C(=O)OC)cc1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
KDM4E B2RXH2 4/20 0.60
NPC1 O15118 3/20 0.60
HPGD P15428 3/20 0.60
MAPT P10636 3/20 0.60
RAB9A P51151 2/20 0.60
GAA P10253 2/20 0.48
HSD17B10 Q99714 2/20 0.48
POLB P06746 1/20 0.48
NR4A1 P22736 1/20 0.48
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.40
OPRK1 P41145 2/20 0.39
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944760 0.88 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9898451 0.86 KDM4E (0.45) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944847 0.82 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944806 0.80 ALDH1A1 (0.41) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944877 0.78 ALDH1A1 (0.46) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944829 0.78 ALDH1A1 (0.39) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9897859 0.77 KDM4E (0.38) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944740 0.77 RAB9A (0.41) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944826 0.77 RAB9A (0.41) ALDH1A1KDM4ENPC1HPGDMAPT
SCHEMBL9944913 0.76 RAB9A (0.43) ALDH1A1KDM4ENPC1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885KDM4E 3442/4885NPC1 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.